Fig. 1From: Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responsesThe effects of kinsenoside on the development and clinical of CIA. a Photograph type (hind paw volume). (b). Clinical scores of CIA were monitored every 5 day after booster immunization. (c)The incidence of arthritic paws overtime was monitored. (*p < 0.05 vs. H2O-treated group, n = 6 in each group)Back to article page